Healthcare
Live Price
Offline$16.35
+9.36% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Bright Health Group, Inc. (BHG) is a Healthcare stock with a market cap of $130.51M. The stock last traded around $16.35. Baseline metrics include revenue growth of -19.3%, EPS growth of +85.0%, a dividend yield of 0.0%. What stands out right now is revenue -19.3%, EPS +85.0%, free cash flow +95.4% with operating margin -1.9% and ROIC 7.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BHG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BHG
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BHG Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BHG and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.2B
-70.0% YoY
FY Net Income
-$248.4M
+78.9% YoY
Free Cash Flow
-$63.7M
-223.4% YoY
Revenue Growth
-19.3%
EPS Growth
+85.0%
Gross Margin
25.1%
Net Margin
-5.8%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 937M | 1.2B | 2.4B | 4.0B | 1.2B |
| Gross Profit | 195M | -123M | 206M | 76M | 160M |
| Operating Income | -102M | -628M | -477M | -1.2B | -258M |
| EBITDA | -149M | -567M | -557M | -1.2B | -249M |
| Net Income | -186M | -1.2B | -638M | -1.2B | -248M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 83M | 466M | 1.1B | 488M | 523M |
| Total Assets | 544M | 4.7B | 3.6B | 1.8B | 820M |
| Total Liabilities | 930M | 3.7B | 2.5B | 2.3B | 1.1B |
| Shareholder Equity | -1.4B | 720M | 1.1B | -504M | -263M |
| Total Debt | 2M | 304M | 155M | 0 | 0 |
| Net Debt | -81M | -162M | -906M | -488M | -523M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
57M
-169.8% YoY
Capital Expenditures
6M
+78.7% YoY
Free Cash Flow
64M
-223.4% YoY
Key ratios
Gross Margin
25.1%
Operating Margin
-1.9%
Net Margin
-5.8%
ROE
8.6%
Debt / Equity
-0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.